financetom
PRLB
financetom
/
Industrials
/
PRLB
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Proto Labs, Inc.PRLB
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce digital manufacturer of custom prototypes and on-demand production parts in the worldwide.

The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.

It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end markets.

Proto Labs, Inc. was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.

Latest News >
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday. ...
Sector Update: Tech
Sector Update: Tech
Jan 13, 2025
01:44 PM EST, 01/13/2025 (MT Newswires) -- Tech stocks declined Monday afternoon with the Technology Select Sector SPDR Fund (XLK) falling 1.1% and the SPDR S&P Semiconductor ETF (XSD) dropping 1.4%. The Philadelphia Semiconductor index shed 0.8%. In corporate news, Clearwater Analytics ( CWAN ) agreed to buy Enfusion ( ENFN ) for $1.5 billion in cash and stock. Enfusion...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
(Reuters) -U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. We are all in ... we are building our teams ... We are recruiting experts in obesity over the last, let's...
Looking At McDonald's's Recent Unusual Options Activity
Looking At McDonald's's Recent Unusual Options Activity
Jan 13, 2025
Deep-pocketed investors have adopted a bearish approach towards McDonald's , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen. We gleaned this information from our observations today...
Copyright 2023-2025 - www.financetom.com All Rights Reserved